Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Symptomatic recurrence of Clostridium difficile infection (CDI) occurs in approximately 20% of patients and is challenging to treat. Identifying those at high risk could allow targeted initial management and improve outcomes. Adult toxin enzyme immunoassay-positive CDI cases in a population of approximately 600,000 persons from September 2006 through December 2010 were combined with epidemiological/clinical data. The cumulative incidence of recurrence ≥ 14 days after the diagnosis and/or onset of first-ever CDI was estimated, treating death without recurrence as a competing risk, and predictors were identified from cause-specific proportional hazards regression models. A total of 1678 adults alive 14 days after their first CDI were included; median age was 77 years, and 1191 (78%) were inpatients. Of these, 363 (22%) experienced a recurrence ≥ 14 days after their first CDI, and 594 (35%) died without recurrence through March 2011. Recurrence risk was independently and significantly higher among patients admitted as emergencies, with previous gastrointestinal ward admission(s), last discharged 4-12 weeks before first diagnosis, and with CDI diagnosed at admission. Recurrence risk also increased with increasing age, previous total hours admitted, and C-reactive protein level at first CDI (all P < .05). The 4-month recurrence risk increased by approximately 5% (absolute) for every 1-point increase in a risk score based on these factors. Risk factors, including increasing age, initial disease severity, and hospital exposure, predict CDI recurrence and identify patients likely to benefit from enhanced initial CDI treatment.

Original publication

DOI

10.1093/cid/cis356

Type

Journal article

Journal

Clinical infectious diseases : an official publication of the infectious diseases society of america

Publication Date

08/2012

Volume

55 Suppl 2

Pages

S77 - S87

Addresses

NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

Keywords

Infections in Oxfordshire Research Database, Humans, Clostridium difficile, Clostridium Infections, Cross Infection, C-Reactive Protein, Immunoenzyme Techniques, Treatment Outcome, Hospitalization, Severity of Illness Index, Incidence, Proportional Hazards Models, Risk Factors, Follow-Up Studies, Predictive Value of Tests, Age Factors, Time Factors, Adolescent, Adult, Aged, Aged, 80 and over, Middle Aged, Child, Female, Male, Secondary Prevention, Young Adult